In experimental animal models, it has shown potential in inhibiting metabolic syndrome, helping to control blood glucose levels and body weight by improving insulin sensitivity and reducing fat accumulation, thus mitigating the progression of metabolic syndrome (A. and I., 2017). The gene discussed is INS; the disease is metabolic syndrome.